Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Juno Therapeutics Inc.
DescriptionT cell receptor (TCR) targeting Wilms tumor 1 (WT1)
Molecular Target Wilms tumor 1 (WT1)
Mechanism of Action 
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today